Sea Cliff Partners Management’s Evolent Health EVH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-1,466,867
Closed -$12.4M 16
2025
Q3
$12.4M Buy
1,466,867
+233,039
+19% +$2.26M 4.75% 13
2025
Q2
$13.9M Sell
1,233,828
-16,330
-1% -$150K 4.74% 12
2025
Q1
$11.8M Buy
1,250,158
+420,158
+51% +$4.24M 4.25% 12
2024
Q4
$9.34M Buy
+830,000
New +$14.6M 3.24% 15

Other funds holding EVH

Sea Cliff Partners Management's EVH Position: Q4 2025 in Review

Sea Cliff Partners Management sold out of Evolent Health (EVH) in Q4 2025, closing a stake of 1,466,867 shares — an estimated $12.4M sold.

Sea Cliff Partners Management first reported a position in EVH in Q4 2024 and held it in 4 quarters. The position peaked at $13.9M in Q2 2025. 215 funds tracked by Wall St. Rank hold EVH as of Q4 2025.

  • Sea Cliff Partners Management reported no remaining Evolent Health position as of Q4 2025 after selling out during the quarter.
  • Sea Cliff Partners Management sold 1,466,867 Evolent Health shares in Q4 2025, an estimated $12.4M.
  • Sea Cliff Partners Management first reported a position in Evolent Health in Q4 2024 and held it in 4 quarters.
  • Sea Cliff Partners Management's Evolent Health position peaked at $13.9M in Q2 2025.
  • 215 funds tracked by Wall St. Rank held Evolent Health as of Q4 2025.

Based on Sea Cliff Partners Management's 13F filing for Q4 2025, filed 17 Feb 2026.